This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) Grant 5 x mille n.9980, (to M.F., F.M. A. N., P.T. and M.N.) ; AIRC I.G. n. 14326 (to M.F.), n.10136 and 16722 (A.N.), n.15426 (to F.F.). AIRC and Fondazione CaRiCal co-financed Multi Unit Regional Grant 2014 n.16695 (to F.M.). Italian Ministry of Health 5x1000 funds (to S.Z. and F.F). A.G R. was supported by Associazione Italiana contro le Leucemie-Linfomi-Mielomi (AIL) Cosenza - Fondazione Amelia Scorza (FAS). S.M. C.M., M.C., L.E., S.B. were supported by AIRC.Peer reviewedPostprin

Baio, G.

Basso, L.

Boccardo, S.

Calabrese, M.

Cilli, M.

Colombo, M.

Cutrona, G.

Emionite, L.

Fabris, S.

Fais, F.

Ferrarini, M.

Gentile, M.

Massara, R .

Massucco, C.

Matis, S.

Morabito, F.

Negrini, M.

Neri, A.

Neumaier, C. E.

Recchia, A. G.

Reverberi, D.

Rosa, F.

Salvi, S.

Tassone, P.

Truini, M.

Valdora, F.

Zupo, S.

Leukemia

English

Chronic lymphocytic leukemia (CLL) clones are characterized by loss of a critical region in 13q14.3, [del(13)(q14)] involving the microRNA (miRNA) cluster miR-15a and miR-16-1. We have investigated the effects of replacement of miR-15a and miR-16-1. CLL cells transfected with these miRNA mimics exhibited a decrease in cell viability in vitro and impaired capacity for engraftment and growth in NOD/Shi-scid,γcnull (NSG) mice. No synergistic effects were observed when the two miRNA mimics were combined. The phenomena were not restricted to CLL with the del(13)(q14) lesion. Similar effects induced by miRNA mimics were seen in cells with additional chromosomal abnormalities with the exception of certain CLL clones harboring TP53 alterations. Administration of miRNA mimics to NSG mice previously engrafted with CLL clones resulted in substantial tumor regression. CLL cell transfection with miR-15a and miR-16-1 specific inhibitors resulted in increased cell viability in vitro and in an enhanced capacity of the engrafted cells to grow in NSG mice generating larger splenic nodules. These data demonstrate that the strong control by miR-15a and miR-16-1 on CLL clonal expansion is exerted also at the level of full-blown leukemia and provide indications for a miRNA based therapeutic strategy

G. Cutrona

S. Matis

M. Colombo

C. Massucco

G. Baio

F. Valdora

L. Emionite

A. G. Recchia

M. Gentile

C. E. Neumaier

D. Reverberi

R. Massara

S. Boccardo

L. Basso

S. Salvi

F. Rosa

M. Cilli

S. Zupo

M. Truini

P. Tassone

M. Calabrese

M. Negrini

F. Morabito

F. Fais

M. Ferrarini

S. Fabris

A. Neri

AIR Universita degli studi di Milano

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: Implication for therapy

This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) Grant 5 x mille n.9980, (to M.F., F.M. A. N., P.T. and M.N.) ; AIRC I.G. n. 14326 (to M.F.), n.10136 and 16722 (A.N.), n.15426 (to F.F.). AIRC and Fondazione CaRiCal co-financed Multi Unit Regional Grant 2014 n.16695 (to F.M.). Italian Ministry of Health 5x1000 funds (to S.Z. and F.F). A.G R. was supported by Associazione Italiana contro le Leucemie-Linfomi-Mielomi (AIL) Cosenza - Fondazione Amelia Scorza (FAS). S.M. C.M., M.C., L.E., S.B. were supported by AIRC.Peer reviewe

Aberdeen University Research

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia : implication for therapy

Chronic lymphocytic leukemia (CLL) clones are characterized by loss of a critical region in 13q14.3, (del(13)(q14)) involving the microRNA (miRNA) cluster miR-15a and miR-16-1. We have investigated the effects of replacement of miR-15a and miR-16-1. CLL cells transfected with these miRNA mimics exhibited a decrease in cell viability in vitro and impaired capacity for engraftment and growth in NOD/Shi-scid,3cnull (NSG) mice. No synergistic effects were observed when the two miRNA mimics were combined. The phenomena were not restricted to CLL with the del(13)(q14) lesion. Similar effects induced by miRNA mimics were seen in cells with additional chromosomal abnormalities with the exception of certain CLL clones harboring TP53 alterations. Administration of miRNA mimics to NSG mice previously engrafted with CLL clones resulted in substantial tumor regression. CLL cell transfection with miR-15a and miR-16-1-specific inhibitors resulted in increased cell viability in vitro and in an enhanced capacity of the engrafted cells to grow in NSG mice generating larger splenic nodules. These data demonstrate that the strong control by miR-15a and miR-16-1 on CLL clonal expansion is exerted also at the level of full-blown leukemia and provide indications for a miRNA-based therapeutic strategy

Massara, R.

NEGRINI, Massimo

Archivio istituzionale della ricerca - Università di Ferrara

Chronic lymphocytic leukemia (CLL) clones are characterized by loss of a critical region in 13q14.3, (del(13)(q14)) involving the microRNA (miRNA) cluster miR-15a and miR-16-1. We have investigated the effects of replacement of miR-15a and miR-16-1. CLL cells transfected with these miRNA mimics exhibited a decrease in cell viability in vitro and impaired capacity for engraftment and growth in NOD/Shi-scid,γcnull (NSG) mice. No synergistic effects were observed when the two miRNA mimics were combined. The phenomena were not restricted to CLL with the del(13)(q14) lesion. Similar effects induced by miRNA mimics were seen in cells with additional chromosomal abnormalities with the exception of certain CLL clones harboring TP53 alterations. Administration of miRNA mimics to NSG mice previously engrafted with CLL clones resulted in substantial tumor regression. CLL cell transfection with miR-15a and miR-16-1-specific inhibitors resulted in increased cell viability in vitro and in an enhanced capacity of the engrafted cells to grow in NSG mice generating larger splenic nodules. These data demonstrate that the strong control by miR-15a and miR-16-1 on CLL clonal expansion is exerted also at the level of full-blown leukemia and provide indications for a miRNA-based therapeutic strategy.Leukemia advance online publication, 3 February 2017; doi:10.1038/leu.2016.394

CUTRONA, GIOVANNA

Matis, S

Colombo, M

Massucco, C

Baio, G

VALDORA, FRANCESCA

EMIONITE, LAURA

Fabris, S

Recchia, A. G

Gentile, M

Neumaier, C. E

Reverberi, D

Massara, R

BOCCARDO, STEFANO

Basso, L

Salvi, S

Rosa, F

Cilli, M

Zupo, S

Truini, M

Tassone, P

Calabrese, M

Negrini, M

Neri, A

Morabito, F

FAIS, FRANCO

FERRARINI, MANLIO

Archivio istituzionale della ricerca - Università di Genova

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy

G Cutrona

S Matis

M Colombo

C Massucco

G Baio

F Valdora

L Emionite

S Fabris

A G Recchia

M Gentile

C E Neumaier

D Reverberi

R Massara

S Boccardo

L Basso

S Salvi

F Rosa

M Cilli

S Zupo

M Truini

P Tassone

M Calabrese

M Negrini

A Neri

F Morabito

F Fais

M Ferrarini

Crossref

https://aura.abdn.ac.uk/bitstream/2164/9070/1/27908_1_merged_1482943197.pdf

Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia : implication for therapy

Abstract

Similar works

Full text

Available Versions

AIR Universita degli studi di Milano

Aberdeen University Research

Archivio istituzionale della ricerca - Università di Ferrara

Archivio istituzionale della ricerca - Università di Ferrara

Archivio istituzionale della ricerca - Università di Genova

Crossref